Delivery Order SPE2DB22D1106-SPE2DB25FFHC5
Award Date 9/5/25
Potential Completion Date 9/8/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Hydralazine 20 mg/mL vials on July 23, 2025, with a ceiling value of $2,186.12. This non-competitive delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction to support federal medical procurement needs. The contract is scheduled for completion on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Hydralazine 20 mg/mL vials totaling $1,482.82. This competitively awarded, non-set-aside contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025. The delivery order represents a firm fixed price transaction with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency (DLA) awarded a $1,798.12 delivery order to AmerisourceBergen Drug Corp for Hydralazine 20 mg/ml vials, with a completion date of September 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,246.98 to AmerisourceBergen Drug Corp for the supply of Hydralazine 20 mg/mL vials under a firm fixed-price contract. The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a non-set-aside competitive award for this cardiovascular medication. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,398.12, is for the supply of 4566821134 Hydralazine 20 mg/ml vials. It is a firm fixed-price, delivery order contract with a completion date of January 3, 2025. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,441.58 firm-fixed-price contract is for the supply of 4565904283 - Hydralazine 20 mg/ml vials. It is not a set-aside contract. The order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and DLA Troop Support Medical, which covers a broad range of pharmaceutical and medical commodities to support...
- This federal contract award is a delivery order (SPE2DB20D3103|SPE2DB25FL6E6) from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4566406249 - Hydralazine 20 mg/ml vial/ml. The $6,809.93 firm fixed-price contract has a completion date of November 13, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation. This award is part of a larger $999,999,999 Indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a $225,240 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20 mg/mL vials of hydralazine. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 29, 2023 through June 30, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this delivery order will provide the DLA with approximately $225,000 worth of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Hydromorphone 1 mg/ml on June 18, 2025, with a ceiling value of $1,103.20 and firm fixed pricing. This is a non-set-aside, competitively awarded contract with performance scheduled to conclude by June 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery order represents a small-value pharmaceutical...
- AmerisourceBergen Drug Corp has been awarded a delivery order contract valued at $1,352.78 for the supply of Hydromorphone 1 mg/mL by the Defense Logistics Agency's Medical Supply Chain on August 6, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery is scheduled for completion by...